Product analysis
Tru Niagen Unflavored offers a clearly identified form of vitamin B3 in an unflavored option.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality47
The vitamin B3 ingredient is clearly identified as nicotinamide riboside chloride. Quality comparisons for the remaining entries remain uncertain.
Ingredient Transparency75
The ingredient amounts are disclosed, and the vitamin B3 form is clearly named. Other entries have less detail about their forms.
Value For Money50
The vitamin B3 ingredient offers moderate value for its serving cost. The remaining information does not support a reliable comparison of the whole formula’s value.
Customer Satisfaction79
Customer feedback is very positive. Several hundred ratings provide useful reassurance about satisfaction without confirming effectiveness.
Product Focus30
A clear cardiovascular benefit cannot be established from the available goal information. The formula contains no ingredient confirmed to be unnecessary.
- Format
Powder - Container
- 120 Gram(s)
- Per serving
- $1.76
- Customer rating
- 4.8 · 443 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 15 Calorie(s) | |
Total Carb. | 4 Gram(s) | |
Niagen (Nicotinamide Riboside Chloride) | 300 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Niacin Form & Goal Alignment
Precursor Source Quality
Dose, Safety & Label Transparency92
Clarity of Chemical Form
Form-Specific Dosage Efficacy
Flush Risk & Safety Labeling
Value60
Price Per Effective Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
- Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
- Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
- Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
- Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
- The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
- Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
- Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
- The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
- Niacinamide: A B vitamin that improves aging facial skin appearance.
- The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial.
- A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
- Nicotinamide for Skin Cancer Chemoprevention.